tetradecanoylphorbol acetate has been researched along with piplartine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, JS; Kim, JA; Ku, SK | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and piplartine
Article | Year |
---|---|
Piperlonguminine downregulates endothelial protein C receptor shedding in vitro and in vivo.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Anti-Inflammatory Agents; Antigens, CD; Cells, Cultured; Dioxolanes; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Protein C Receptor; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fruit; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Phytotherapy; Piper; Plant Extracts; Plants, Medicinal; Receptors, Cell Surface; Sepsis; Tetradecanoylphorbol Acetate; Time Factors; Tumor Necrosis Factor-alpha | 2014 |